Diagnostic Accuracy of HLA-B*57:01 Screening for The Prediction of Abacavir Hypersensitivity and Clinical Utility of the Test: A Meta-Analytic Review
Copyright policy )Diagnostic Accuracy of HLA-B*57:01 Screening for The Prediction of Abacavir Hypersensitivity and Clinical Utility of the Test: A Meta-Analytic Review
To determine diagnostic accuracy of HLA-B*57:01 testing for prediction of abacavir-induced hypersensitivity and to quantify the clinical benefit of pretreatment screening through a meta-analytic review of published studies.A comprehensive search was performed up to June 2013. The methodological quality of relevant studies was assessed by the QUADAS-2 tool. The pooled diagnostic estimates were calculated using a random effect model.Despite the presence of heterogeneity in sensitivity or specificity estimates, the pooled diagnostic odds ratio to detect abacavir-induced hypersensitivity on the basis of clinical criteria was 33.07 (95% CI: 22.33-48.97, I(2): 13.9%), while diagnostic odds ratio for detection of immunologically confirmed abacavir hypersensitivity was 1141 (95% CI: 409-3181, I(2): 0%). Pooled analysis of risk ratio showed that prospective HLA-B*57:01 testing significantly reduced the incidence of abacavir-induced hypersensitivity.This meta-analysis demonstrates an excellent diagnostic accuracy of HLA-B*57:01 testing to detect immunologically confirmed abacavir hypersensitivity and corroborates existing recommendations.
Anti-HIV Agents, clinical utility, 610, HIV Infections, meta-analysi, 618, Drug Hypersensitivity, abacavir hypersensitivity, Humans, HIV Infection, Genetic Testing, HLA-B*57:01; abacavir hypersensitivity; clinical utility; diagnostic accuracy; meta-analysis; Anti-HIV Agents; Dideoxynucleosides; Drug Hypersensitivity; Genetic Testing; HIV Infections; HLA-B Antigens; Humans; Pharmacogenetics, Anti-HIV Agent, HLA-B*57:01, Dideoxynucleoside, Dideoxynucleosides, HLA-B Antigen, HLA-B Antigens, Pharmacogenetics, diagnostic accuracy, Human
Anti-HIV Agents, clinical utility, 610, HIV Infections, meta-analysi, 618, Drug Hypersensitivity, abacavir hypersensitivity, Humans, HIV Infection, Genetic Testing, HLA-B*57:01; abacavir hypersensitivity; clinical utility; diagnostic accuracy; meta-analysis; Anti-HIV Agents; Dideoxynucleosides; Drug Hypersensitivity; Genetic Testing; HIV Infections; HLA-B Antigens; Humans; Pharmacogenetics, Anti-HIV Agent, HLA-B*57:01, Dideoxynucleoside, Dideoxynucleosides, HLA-B Antigen, HLA-B Antigens, Pharmacogenetics, diagnostic accuracy, Human
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!